Related Experiment Video
Updated: Jul 17, 2026

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
Potent antitubulin tumor cell cytotoxins based on 3-aroyl indazoles
Jian-Xin Duan1, Xiaohong Cai, Fanying Meng
1Threshold Pharmaceuticals, 1300 Seaport Boulevard, Redwood City, California 94063, USA. jduan@thresholdpharm.com
Abstract:
A series of 3-aroyl indazoles was synthesized. Modification of the C-7 position resulted in a significant structure-activity relationship (SAR) with acetylene modifications conferring unusual potency in a tumor cell cytotoxicity assay. The most potent compounds exceeded the activity of combretastatin A4 (CA-4), showing single digit nM IC50 values against all cell lines tested including those with known efflux resistance pumps. The inhibition of in vitro tubulin polymerization was comparable to CA-4, consistent with tubulin being the target for these compounds. Competition binding experiments employing [3H]colchicine and purified tubulins demonstrated that the compound specifically binds to the colchicine site.
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Anthelminthic Agents
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Destabilization of Microtubules
